骨骼及關節保健品市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、配方、消費群組、銷售管道、地區及競爭格局分類，2021-2031年）

全球骨骼和關節健康補充劑市場預計將從 2025 年的 31.6 億美元成長到 2031 年的 44.5 億美元，複合年成長率為 5.87%。

這些營養補充品通常含有鈣、維生素D、葡萄糖胺、軟骨素和膠原蛋白等成分，旨在維持骨骼完整性並支持關節功能。該市場的成長主要受全球人口老化（老年人更容易出現肌肉骨骼問題）以及越來越多的年輕消費者採取預防措施以確保長期行動能力的驅動。這些根本性因素正在創造持續的、由人口結構驅動的需求，即對能夠緩解老齡化帶來的生理影響並支持積極生活方式的產品的需求，這使其區別於短暫的市場趨勢。

然而，該行業面臨著許多挑戰，其中最主要的障礙是嚴格的法規環境，這限制了健康聲明的證實，也阻礙了新產品的進入。儘管有這些監管挑戰，消費者對經科學驗證的成分的支持依然強勁。例如，負責任營養委員會（Council for Responsible Nutrition）報告稱，到2024年，鎂（維持骨骼密度所必需的元素）的使用率在膳食補充劑使用者中上升至23%，這凸顯了消費者對經科學檢驗的骨骼健康成分的持續依賴。

市場促進因素

全球老年人口的快速成長是骨骼和關節保健品市場的主要驅動力。全球人口結構的變化正促使越來越多的人步入與自然老齡化相關的骨骼密度流失年齡段，從而推動了對治療性和預防性配方產品的穩定需求。這代表著一種持續的結構性轉變，而非暫時的激增，確保了維生素D、鈣和骨骼強化礦物質的基本攝取量。根據世界經濟論壇2025年10月發布的報導《我們是否走在實現健康老化的正確道路上？ 》，預計到2030年，60歲及以上人口將達到14億，這將為肌肉骨骼健康解決方案創造一個龐大且穩定的消費群。

同時，運動營養補充品在年輕消費者中日益普及，正將市場從老年照護拓展到支持積極生活方式的領域。年輕消費者擴大使用膠原蛋白、蛋白質和關節保健補充劑，並非出於治療目的，而是為了促進運動後的恢復，並在劇烈運動中維護關節健康。這一趨勢正在推動以提升運動表現為導向的品類的銷售，並促進了預防性補充劑的普及。為了佐證這一商業性潛力，Glanbia 在 2025 年 2 月公佈的「2024 會計年度」全年業績報告中，旗下 Optimum Nutrition 品牌實現了 7.5% 的營收成長。此外，Thorne HealthTech 報告稱，其 2025 年的收入約為 3.94 億美元，這反映了個人化健康配方所釋放的巨大價值。

市場挑戰

對健康聲明的嚴格法規環境對全球骨骼和關節保健品市場構成了重大障礙。監管機構嚴格區分膳食補充劑和藥品，要求提供大量的科學證據來證實其功效。這個框架禁止製造商做出諸如「治療」或「治癒」某些肌肉骨骼疾病（例如骨質疏鬆症或關節炎）的明確聲明。因此，企業只能做出更溫和的“結構和功能聲明”，而這些聲明可能無法充分向患有運動障礙或慢性疼痛的消費者傳達其產品的治療潛力。這導致合規成本高昂，並扼殺了創新。

這些監管限制嚴重限制了該行業利用消費者對天然健康解決方案日益成長的需求的能力。根據責任營養委員會2024年的數據，約80%的膳食補充劑使用者在適當情況下更傾向於選擇補充劑而非處方藥或非處方藥。儘管消費者對非藥物干預的需求如此明確，但嚴格的標籤法規卻阻礙了製造商將產品定位為傳統藥物的直接替代品。因此，企業無法有效傳達其產品在維護骨骼和關節健康方面的全部益處，導致商機損失和市場擴張受阻。

市場趨勢

軟糖、液體和粉末劑型的擴張正在從根本上改變全球骨骼和關節健康補充劑市場，有效緩解了消費者對藥片的疲勞感。製造商正逐步拋棄體積大、難以吞嚥的片劑，轉而專注於開發偏好的咀嚼片和機能飲料，這些產品在不影響療效的前提下，融入了葡萄糖胺等複雜的關節支持成分。這種由消費者對便利性需求驅動的轉變，促使契約製造生產商大力投資於掩味和質感技術。 2024年5月，Sirio Pharma在一份題為「Sirio Pharma宣布營收快速成長」的新聞稿中宣布，軟糖補充劑的銷售額同比成長約24.8%，凸顯了替代劑型（如軟糖、液體和粉末）在傳統固態片劑之外的快速發展。

同時，永續採購和優先使用對環境負責的海洋成分正成為品牌吸引具有環保意識的消費者的關鍵差異化因素。各公司正積極尋求供應鏈認證，以確保膠原蛋白和Omega-3脂肪酸等關鍵海洋成分的捕撈方式能夠防止過度捕撈並最大程度地減少對生態系統的影響。這一趨勢迫使成分供應商採用循環經濟實踐和嚴格的可追溯性標準，以證明其對環境的承諾。例如，Aker BioMarine於2025年3月發布的2024年度報告顯示，其永續超級寶甲魚油的銷量成長了15%，這證實了該行業對符合倫理規範捕撈的海洋生物活性成分的依賴性日益增強。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球骨骼與關節保健品市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品（維生素、礦物質、膠原蛋白、 Omega-3、葡萄糖胺、其他）
  • 按劑型（膠囊、錠劑、粉末、軟膠囊等）
  • 消費群組（嬰兒、兒童、成人、孕婦、老年人）分類
  • 依銷售管道（實體店（直銷、藥局、保健食品店、大型超市、超級市場）、電子商務）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美骨骼與關節保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲骨骼與關節保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區骨骼與關節保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東及非洲骨骼及關節保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲骨骼與關節保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球骨骼與關節保健品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Herbalife International of America, Inc.
• GNC Holdings, LLC
• Nature's Bounty
• BYHEALTH Co., Ltd.
• Amway
• BASF SE
• Bayer AG
• Vitalife Ltd
• Glanbia plc
• NOW Foods

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Bone And Joint Health Supplements Market is projected to expand from USD 3.16 Billion in 2025 to USD 4.45 Billion by 2031, registering a CAGR of 5.87%. These dietary formulations typically contain ingredients such as calcium, vitamin D, glucosamine, chondroitin, and collagen, aimed at preserving skeletal integrity and supporting joint function. The market is primarily propelled by a globally aging population prone to musculoskeletal issues and a growing demographic of younger consumers adopting preventative measures to ensure long-term mobility. These fundamental drivers create a consistent, demographic-based demand for products that counteract the physical impacts of aging and support active lifestyles, distinguishing them from fleeting market trends.

However, the industry faces a significant obstacle in the form of a strict regulatory environment regarding health claim substantiation, which creates barriers for new product entries. Despite these regulatory challenges, consumer commitment to proven ingredients remains strong. For instance, the 'Council for Responsible Nutrition' reported in '2024' that magnesium usage, which is vital for maintaining bone density, increased to 23 percent among supplement users, highlighting the continued reliance on scientifically validated ingredients for skeletal health.

Market Driver

The Rapidly Expanding Global Geriatric Population acts as the primary force driving the bone and joint health supplements market. As demographics shift worldwide, a larger segment of the population is entering age groups associated with natural bone density loss, fueling a steady demand for both therapeutic and preventative formulations. This represents a lasting structural change rather than a temporary surge, ensuring baseline consumption of vitamin D, calcium, and bone-fortifying minerals. According to the World Economic Forum's October 2025 article 'Are we on track when it comes to healthy ageing?', the global population aged 60 and older is expected to reach 1.4 billion by 2030, establishing a vast and permanent consumer base for musculoskeletal health solutions.

Concurrently, the Growing Adoption of Sports Nutrition Among Younger Demographics is broadening the market's reach beyond senior care to include active lifestyle support. Younger consumers are increasingly using collagen, protein, and joint-support supplements to aid recovery and maintain joint health during rigorous physical activities, rather than for treatment purposes. This trend boosts sales in performance-focused categories, confirming a shift toward preventive supplementation. As evidence of this commercial strength, Glanbia plc reported in its '2024 Full Year Results' in February 2025 that its 'Optimum Nutrition' brand achieved 7.5 percent revenue growth. Furthermore, Thorne HealthTech reported 2025 revenues of approximately 394 million USD, reflecting the significant value generated by personalized wellness formulations.

Market Challenge

The stringent regulatory environment regarding health claim substantiation presents a major hurdle for the "Global Bone And Joint Health Supplements Market". Regulatory bodies enforce strict distinctions between dietary supplements and pharmaceutical drugs, necessitating extensive scientific proof to validate efficacy. This framework prohibits manufacturers from making explicit claims about curing or treating specific musculoskeletal conditions such as osteoporosis or arthritis. Consequently, companies are restricted to making softer structure and function claims that may not fully communicate the therapeutic potential of their products to consumers suffering from immobility or chronic pain, leading to high compliance costs and stifled innovation.

These regulatory limitations severely restrict the industry's ability to capitalize on the growing consumer preference for natural health solutions. Data from the 'Council for Responsible Nutrition' in '2024' indicated that nearly 80 percent of dietary supplement users prefer supplements over prescription or over-the-counter medications when appropriate. Despite this clear demand for non-pharmaceutical interventions, strict labeling laws prevent manufacturers from positioning their products as direct alternatives to conventional medicine. As a result, companies cannot effectively convey the full benefits of their bone and joint health formulations, resulting in missed revenue opportunities and hampered market expansion.

Market Trends

The Diversification into Gummy, Liquid, and Powder Delivery Formats is fundamentally transforming the Global Bone And Joint Health Supplements Market by addressing consumer pill fatigue. Manufacturers are shifting away from large, difficult-to-swallow tablets to create palatable chewables and functional beverages that incorporate complex joint-support ingredients like glucosamine without sacrificing efficacy. This transition is driven by a demand for convenience, compelling contract manufacturers to invest heavily in flavor masking and texture technologies. In May 2024, Sirio Pharma announced in its 'Sirio Pharma announces surge in revenue' press release that its gummy supplement sales grew by approximately 24.8 percent year-over-year, highlighting the rapid expansion of alternative delivery systems over traditional solid forms.

Simultaneously, the Prioritization of Sustainably Sourced and Eco-Friendly Marine Ingredients is becoming a critical differentiator for brands aiming to align with environmentally conscious consumers. Companies are aggressively certifying their supply chains to ensure that key marine inputs, such as collagen and omega-3 fatty acids, are harvested using methods that prevent overfishing and minimize ecosystem impact. This trend forces ingredient suppliers to adopt circular economy practices and rigorous traceability standards to validate their ecological credentials. Illustrating this shift, Aker BioMarine's 'Annual Report 2024', released in March 2025, showed a 15 percent increase in sales of its sustainable Superba krill oil, confirming the industry's growing reliance on ethically harvested marine bioactives.

Key Market Players

• Herbalife International of America, Inc.
• GNC Holdings, LLC
• Nature's Bounty
• BYHEALTH Co., Ltd.
• Amway
• BASF SE
• Bayer AG
• Vitalife Ltd
• Glanbia plc
• NOW Foods

Report Scope

In this report, the Global Bone And Joint Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone And Joint Health Supplements Market, By Product

• Vitamins
• Mineral
• Collagen
• Omega-3
• Glucosamine
• Others

Bone And Joint Health Supplements Market, By Formulation

• Capsules
• Tablets
• Powders
• Softgels
• Others

Bone And Joint Health Supplements Market, By Consumer Group

• Infants
• Children
• Adults
• Pregnant Women
• Geriatric Population

Bone And Joint Health Supplements Market, By Sales Channel

• Bricks And Mortar (Direct Selling, Chemists/Pharmacies, Health Food Shops, Hyper Markets, Super Markets)
• E-Commerce

Bone And Joint Health Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone And Joint Health Supplements Market.

Available Customizations:

Global Bone And Joint Health Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone And Joint Health Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Vitamins, Mineral, Collagen, Omega-3, Glucosamine, Others)
  • 5.2.2. By Formulation (Capsules, Tablets, Powders, Softgels, Others)
  • 5.2.3. By Consumer Group (Infants, Children, Adults, Pregnant Women, Geriatric Population)
  • 5.2.4. By Sales Channel (Bricks And Mortar (Direct Selling, Chemists/Pharmacies, Health Food Shops, Hyper Markets, Super Markets), E-Commerce)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Bone And Joint Health Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Formulation
  • 6.2.3. By Consumer Group
  • 6.2.4. By Sales Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bone And Joint Health Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Formulation
      • 6.3.1.2.3. By Consumer Group
      • 6.3.1.2.4. By Sales Channel
  • 6.3.2. Canada Bone And Joint Health Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Formulation
      • 6.3.2.2.3. By Consumer Group
      • 6.3.2.2.4. By Sales Channel
  • 6.3.3. Mexico Bone And Joint Health Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Formulation
      • 6.3.3.2.3. By Consumer Group
      • 6.3.3.2.4. By Sales Channel

7. Europe Bone And Joint Health Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Formulation
  • 7.2.3. By Consumer Group
  • 7.2.4. By Sales Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bone And Joint Health Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Formulation
      • 7.3.1.2.3. By Consumer Group
      • 7.3.1.2.4. By Sales Channel
  • 7.3.2. France Bone And Joint Health Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Formulation
      • 7.3.2.2.3. By Consumer Group
      • 7.3.2.2.4. By Sales Channel
  • 7.3.3. United Kingdom Bone And Joint Health Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Formulation
      • 7.3.3.2.3. By Consumer Group
      • 7.3.3.2.4. By Sales Channel
  • 7.3.4. Italy Bone And Joint Health Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Formulation
      • 7.3.4.2.3. By Consumer Group
      • 7.3.4.2.4. By Sales Channel
  • 7.3.5. Spain Bone And Joint Health Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Formulation
      • 7.3.5.2.3. By Consumer Group
      • 7.3.5.2.4. By Sales Channel

8. Asia Pacific Bone And Joint Health Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Formulation
  • 8.2.3. By Consumer Group
  • 8.2.4. By Sales Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bone And Joint Health Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Formulation
      • 8.3.1.2.3. By Consumer Group
      • 8.3.1.2.4. By Sales Channel
  • 8.3.2. India Bone And Joint Health Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Formulation
      • 8.3.2.2.3. By Consumer Group
      • 8.3.2.2.4. By Sales Channel
  • 8.3.3. Japan Bone And Joint Health Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Formulation
      • 8.3.3.2.3. By Consumer Group
      • 8.3.3.2.4. By Sales Channel
  • 8.3.4. South Korea Bone And Joint Health Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Formulation
      • 8.3.4.2.3. By Consumer Group
      • 8.3.4.2.4. By Sales Channel
  • 8.3.5. Australia Bone And Joint Health Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Formulation
      • 8.3.5.2.3. By Consumer Group
      • 8.3.5.2.4. By Sales Channel

9. Middle East & Africa Bone And Joint Health Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Formulation
  • 9.2.3. By Consumer Group
  • 9.2.4. By Sales Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bone And Joint Health Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Formulation
      • 9.3.1.2.3. By Consumer Group
      • 9.3.1.2.4. By Sales Channel
  • 9.3.2. UAE Bone And Joint Health Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Formulation
      • 9.3.2.2.3. By Consumer Group
      • 9.3.2.2.4. By Sales Channel
  • 9.3.3. South Africa Bone And Joint Health Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Formulation
      • 9.3.3.2.3. By Consumer Group
      • 9.3.3.2.4. By Sales Channel

10. South America Bone And Joint Health Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Formulation
  • 10.2.3. By Consumer Group
  • 10.2.4. By Sales Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bone And Joint Health Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Formulation
      • 10.3.1.2.3. By Consumer Group
      • 10.3.1.2.4. By Sales Channel
  • 10.3.2. Colombia Bone And Joint Health Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Formulation
      • 10.3.2.2.3. By Consumer Group
      • 10.3.2.2.4. By Sales Channel
  • 10.3.3. Argentina Bone And Joint Health Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Formulation
      • 10.3.3.2.3. By Consumer Group
      • 10.3.3.2.4. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bone And Joint Health Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Herbalife International of America, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GNC Holdings, LLC
• 15.3. Nature's Bounty
• 15.4. BYHEALTH Co., Ltd.
• 15.5. Amway
• 15.6. BASF SE
• 15.7. Bayer AG
• 15.8. Vitalife Ltd
• 15.9. Glanbia plc
• 15.10. NOW Foods

16. Strategic Recommendations

17. About Us & Disclaimer